Sabra Healthcare Reit (SBRA) has disclosed a new risk, in the Regulation category.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Sabra Healthcare REIT has reported that there have been no material changes in their assessment of risk factors as outlined in their 2024 Annual Report on Form 10-K. This suggests that the company perceives its risk environment to be stable, with no new significant threats identified. Investors and stakeholders should consider this stability in risk assessment when evaluating the company’s future performance. However, it remains crucial to monitor any potential developments that could alter this risk landscape.
The average SBRA stock price target is $19.40, implying 6.71% upside potential.
To learn more about Sabra Healthcare Reit’s risk factors, click here.